Page 8 - Bart Filius News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(GLPGF), (GLPG) - Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts

(GLPGF), (GLPG) - Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Bart filiusLead toledo

Galapagos NV: Galapagos refocuses pipeline and rightsizes operations

Galapagos NV: Galapagos refocuses pipeline and rightsizes operations Filgotinib launch in Europe on track Initiated unaudited the . These last months, we completed a review of our portfolio and development plans with the goal to select a more risk-balanced pipeline. We decided to retain our focus on novel targets to address unmet medical needs in inflammation, fibrosis, and kidney diseases. We also remain fully committed to the launch of Jyseleca in Europe. Moving forward with confidence, we decided to: Refocus our clinical pipeline by critically examining its risk profile and breadth; Cut significant cost in the organization to support this re-sized pipeline development;

Region flamandeUnited kingdomVan gijselElizabeth goodwinRaj parekhBart filiusCarmen vroonenKyra obolenskyEuropean commissionGilead sciences incExchange commissionJapanese ministry of healthGlobal head of communications public affairsCorporate communicationsCommittee for medicinal products human useStandard international

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos refocuses pipeline and rightsizes operations

. “These last months, we completed a review of our portfolio and development plans with the goal to select a more risk-balanced pipeline. We decided to retain our focus on novel targets to address unmet medical needs in inflammation, fibrosis, and kidney diseases. We also remain fully committed to the launch of Jyseleca in Europe. Moving forward with confidence, we decided to: Refocus our clinical pipeline by critically examining its risk profile and breadth; Cut significant cost in the organization to support this re-sized pipeline development; Task our business development team to identify and execute on a transformative opportunity. We believe that our strong cash position, expert teams, and solid scientific foundation position us well for future growth,” said Onno van de Stolpe, CEO of Galapagos.

Region flamandeUnited statesUnited kingdomVan gijselElizabeth goodwinRaj parekhBart filiusCarmen vroonenKyra obolenskyEuropean commissionGilead sciences incExchange commissionJapanese ministry of healthCorporate communicationsGlobal head of communications public affairsCommittee for medicinal products human use

Galapagos refocuses pipeline and rightsizes operations

Galapagos refocuses pipeline and rightsizes operations May 06, 2021 16:01 ET | Source: Galapagos NV Galapagos NV Filgotinib launch in Europe on track Initiated unaudited the . “These last months, we completed a review of our portfolio and development plans with the goal to select a more risk-balanced pipeline. We decided to retain our focus on novel targets to address unmet medical needs in inflammation, fibrosis, and kidney diseases. We also remain fully committed to the launch of Jyseleca in Europe. Moving forward with confidence, we decided to: Refocus our clinical pipeline by critically examining its risk profile and breadth; Cut significant cost in the organization to support this re-sized pipeline development;

Region flamandeUnited kingdomBart filiusCommittee for medicinal products human useMedicinal productsHuman useஒன்றுபட்டது கிஂக்டம்குழு க்கு மருத்துவ ப்ராடக்ட்ஸ் மனிதன் பயன்பாடுமருத்துவ ப்ராடக்ட்ஸ்மனிதன் பயன்பாடு

Extension of lock-up period in Gilead-Galapagos collaboration agreement

Extension of lock-up period in Gilead-Galapagos collaboration agreement
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Region flamandeAndrew dickinsonVan gijselElizabeth goodwinBart filiusCarmen vroonenKyra obolenskyCorporate communicationsGlobal head communications public affairsInflammatory bowel diseasePrivate securities litigation reform actAnnual reportஆண்ட்ரூ டிக்கின்சன்எலிசபெத் குட்வின்பெருநிறுவன தகவல்தொடர்புகள்உலகளாவிய தலை தகவல்தொடர்புகள் பொது வாழ்க்கைத்தொழில்கள்